INNOSPEC INC

For the period ended Sep 30, 2024. Filed Nov 6, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 6, 2024

IOSP$80.21+2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in millions, except share and per share data)	September 30,2024	December 31,2023
Assets
Current assets:
Cash and cash equivalents	$303.8	$203.7
Trade and other accounts receivable (less allowances of $9.5 million and $10.3 million respectively)	327.6	359.8
Inventories (less allowances of $34.9 million and $28.1 million respectively):
Finished goods	221.1	215.7
Raw materials	98.2	84.4
Total inventories	319.3	300.1
Prepaid expenses	9.2	18.7
Prepaid income taxes	5.1	2.8
Other current assets	0.6	0.6
Total current assets	965.6	885.7
Net property, plant and equipment	278.2	268.3
Operating lease right-of-use assets	45.5	45.1
Goodwill	392.3	399.3
Other intangible assets	63.6	57.3
Deferred tax assets	10.5	10.4
Pension asset	38.1	35.1
Other non-current assets	3.9	6.2
Total assets	$1,797.7	$1,707.4

Liabilities and Equity
Current liabilities:
Accounts payable	$169.0	$163.6
Accrued liabilities	170.0	185.9
Current portion of operating lease liabilities	14.0	13.6
Current portion of plant closure provisions	4.6	4.6
Current portion of accrued income taxes	15.5	2.6
Current portion of unrecognized tax benefits	—	1.2
Total current liabilities	373.1	371.5
Operating lease liabilities, net of current portion	31.7	31.6
Plant closure provisions, net of current portion	58.7	57.0
Accrued income taxes, net of current portion	—	11.6
Unrecognized tax benefits	11.0	13.6
Deferred tax liabilities	35.8	33.5
Pension liabilities and post-employment benefits	13.3	13.3
Acquisition-related contingent consideration	21.5	23.4
Other non-current liabilities	5.0	2.3
Total liabilities	550.1	557.8
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	366.6	361.0
Treasury stock (4,612,904 and 4,686,511 shares at cost, respectively)	(93.4)	(94.3)
Retained earnings	1,115.2	1,028.2
Accumulated other comprehensive loss	(145.3)	(148.1)
Total Innospec stockholders’ equity	1,243.4	1,147.1
Non-controlling interest	4.2	2.5
Total equity	1,247.6	1,149.6
Total liabilities and equity	$1,797.7	$1,707.4

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.